Postponed
The inaugural Patient-Centric Cell Therapy Supply Chain Summit will gather senior Heads of Cell Therapy, Logistics and Supply Chain experts to share practical solutions in overcoming common logistics and supply chain challenges for organization's preparing for commercialization. The Summit will also focus on delivering practical knowledge on how to optimize and re-design your processes while ensuring that you have the right technologies and partners while creating and maintaining a patient-centric supply chain in the commercial world.
We are delighted to confirm David Kim, Global Logistics Manager from Kite Pharma, as our opening Keynote Speaker.
David will deliver an inspiring keynote on "Moving to a Patient-Centric Mindset in Cell and Gene Therapy"
Early Confirmed Speakers:
- David Kim, Global Logistics Manager, Kite Pharma
- Allison Matthews, Service Designer, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
- Chris Baldwin, Global Supply Chain Director, Cell and Gene Therapy, GSK
- Craig Beasley, VP Supply Chain, Cell Therapy, Bristol Myers Squibb
- Albert Ribickas, Manager BMT/QC laboratories Cell Therapy Facility, Moffitt Cancer Center
- Sanjay Srivastava, Managing Director for Cell & Gene, Life Sciences, Accenture
- Joe Rininger, Director, Cell and Gene Therapy, Latham BioPharm Group
Our Thought Leaders
Allison Matthews
Service Designer, Innovation and Design
Mayo Clinic
Albert Ribickas
Manager BMT/QC laboratories Cell Therapy Facility
Moffitt Cancer Center
Sanjay Srivastava PhD
Managing Director for Cell & Gene, Life Sciences
Accenture
Craig Beasley
VP Supply Chain, Cell Therapy
Bristol-Myers Squibb
Chris Baldwin
Global Supply Chain Director, Cell and Gene Therapy
GSK
Vincent Carrano
Director of Director of Development & Engagement
Emily Whitehead Foundation
David Kim
Director of Global Logistics
Kite Pharma, a Gilead Company
Julia Tarasenko
Senior Director, US Strategic Account Team
Marken
George W Buchman Ph.D
Vice President, Preclinical and Process Development
Catalent Biologics | Paragon Gene Therapy
Carlo Guy
Executive Director Supply Chain (Cell & Gene Therapies)
.
Rajanikanth (Raj) Bandaru
Regulatory Affairs Director
Accenture Applied Life Science Solutions
Boro Dropulić
Chief Scientific Officer
Lentigen, a Miltenyi Company
Dr Nan Zhang
GMP Cellular Therapy Lead
Children's National Health System
Main Themes Include:
Managing Supply Chain: Overcoming Order Management and Fulfilment Complications
Operating Frameworks: Ensuring chain of custody and Maintaining Product quality and Temperature
Overcoming Challenges in Development & Commercialization
Moving to a Patient-Centric Mindset in Cell and Gene Therapy
Overcoming Infrastructural and Technological Challenges for Cell Therapy Supply Chains
What you can expect
Join the experts to the first end-to-end Summit focused on Cell Therapy Supply Chain to discuss the challenging issues in process development and logistics
Get and understanding how to build a sustainable supply chain which will allow commercial success
We believe in diversity of opinions: take advantage of learning not only from pharma perspective but hospitals, patients, CMO, solutions and service providers, etc.
Networking! Networking! Networking! Use this opportunity to connect with Best and Brightest!
Sponsors & Exhibitors
Media Partners
In Partnership With :
QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com
©2024 IQPC. All rights reserved.
